The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 15 11 2021
accepted: 20 01 2022
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

The incidence of cardiovascular diseases is increasing worldwide with the growing aging of the population. Biological aging has major influence on the vascular tree and is associated with critical changes in the morphology and function of the arterial wall together with an extensive remodeling of the vascular extracellular matrix. Elastic fibers fragmentation and release of elastin degradation products, also known as elastin-derived peptides (EDPs), are typical hallmarks of aged conduit arteries. Along with the direct consequences of elastin fragmentation on the mechanical properties of arteries, the release of EDPs has been shown to modulate the development and/or progression of diverse vascular and metabolic diseases including atherosclerosis, thrombosis, type 2 diabetes and nonalcoholic steatohepatitis. Most of the biological effects mediated by these bioactive peptides are due to a peculiar membrane receptor called elastin receptor complex (ERC). This heterotrimeric receptor contains a peripheral protein called elastin-binding protein, the protective protein/cathepsin A, and a transmembrane sialidase, the neuraminidase-1 (NEU1). In this review, after an introductive part on the consequences of aging on the vasculature and the release of EDPs, we describe the composition of the ERC, the signaling pathways triggered by this receptor, and the current pharmacological strategies targeting ERC activation. Finally, we present and discuss new regulatory functions that have emerged over the last few years for the ERC through desialylation of membrane glycoproteins by NEU1, and its potential implication in receptor transactivation.

Identifiants

pubmed: 35222273
doi: 10.3389/fendo.2022.815356
pmc: PMC8873114
doi:

Substances chimiques

Peptides 0
Receptors, Cell Surface 0
elastin-binding proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

815356

Informations de copyright

Copyright © 2022 Tembely, Henry, Vanalderwiert, Toussaint, Bennasroune, Blaise, Sartelet, Jaisson, Galés, Martiny, Duca, Romier-Crouzet and Maurice.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer, AP, declared a past collaboration with one of the authors, LM, to the handling editor.

Références

J Biol Chem. 2009 Oct 16;284(42):28616-23
pubmed: 19617625
J Cell Biol. 1988 Nov;107(5):1987-93
pubmed: 2846590
J Biol Chem. 1991 Aug 5;266(22):14754-62
pubmed: 1907282
Antimicrob Agents Chemother. 2008 Oct;52(10):3484-91
pubmed: 18694948
Bioorg Med Chem. 2018 Oct 15;26(19):5349-5358
pubmed: 29903413
Cell Signal. 2018 Mar;43:71-84
pubmed: 29277445
J Immunol. 2016 Jun 1;196(11):4536-43
pubmed: 27183603
Nat Rev Genet. 2020 Feb;21(2):88-101
pubmed: 31690828
J Biol Chem. 2012 Mar 9;287(11):8214-31
pubmed: 22247545
Glia. 2009 Dec;57(16):1716-26
pubmed: 19373935
Front Cell Dev Biol. 2020 Dec 16;8:611121
pubmed: 33392200
J Pharmacol Exp Ther. 2021 Jan;376(1):136-146
pubmed: 33139318
Bioorg Chem. 2021 Feb;107:104526
pubmed: 33309269
Int J Biochem Cell Biol. 2008;40(8):1581-96
pubmed: 18206415
J Biol Chem. 2014 Jan 17;289(3):1467-77
pubmed: 24293364
Front Pharmacol. 2016 Mar 04;7:32
pubmed: 26973522
Front Bioeng Biotechnol. 2021 Feb 25;9:643110
pubmed: 33718344
Sci Rep. 2016 Dec 05;6:38363
pubmed: 27917893
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
FEBS Lett. 2002 Jul 31;524(1-3):193-8
pubmed: 12135766
Trends Pharmacol Sci. 2018 Apr;39(4):367-386
pubmed: 29395118
Mol Pharmacol. 2005 Apr;67(4):1315-24
pubmed: 15653554
Science. 1988 Mar 25;239(4847):1539-41
pubmed: 2832941
Circulation. 2006 Oct 24;114(17):1855-62
pubmed: 17030689
J Mol Graph Model. 2006 Oct;25(2):196-207
pubmed: 16427342
Cell Signal. 2010 Aug;22(8):1193-205
pubmed: 20347965
FEBS J. 2019 Aug;286(15):2980-2993
pubmed: 30946528
FEBS Lett. 1989 Nov 20;258(1):5-8
pubmed: 2556298
Arch Dermatol Res. 1997 Jul;289(8):489-92
pubmed: 9266029
J Clin Invest. 2006 Mar;116(3):753-9
pubmed: 16470245
J Biol Chem. 2011 Oct 21;286(42):36532-49
pubmed: 21873432
Nat Protoc. 2010 Jul;5(7):1281-93
pubmed: 20595957
Hum Mol Genet. 2013 Feb 1;22(3):433-43
pubmed: 23100322
J Biol Chem. 2013 Jan 11;288(2):1317-28
pubmed: 23166321
FASEB J. 2007 Jul;21(9):1968-78
pubmed: 17341689
J Biol Chem. 2006 Feb 10;281(6):3698-710
pubmed: 16314420
Biomolecules. 2020 Dec 30;11(1):
pubmed: 33396696
Trends Pharmacol Sci. 2007 Dec;28(12):602-7
pubmed: 18001849
Structure. 1993 Sep 15;1(1):19-26
pubmed: 8069621
Cell Signal. 2013 Nov;25(11):2093-105
pubmed: 23827939
Biochemistry. 1986 Sep 9;25(18):5172-6
pubmed: 2429696
C R Acad Sci III. 1992;315(12):473-8
pubmed: 1297524
Cell. 2021 Jan 21;184(2):306-322
pubmed: 33450206
Int J Cancer. 2008 May 1;122(9):1972-80
pubmed: 18076073
Biochemistry. 1989 May 2;28(9):3716-22
pubmed: 2546580
Cardiovasc Res. 2014 Apr 1;102(1):118-27
pubmed: 24357053
Int Rev Cell Mol Biol. 2018;339:1-40
pubmed: 29776602
Cell Signal. 2010 Feb;22(2):314-24
pubmed: 19796680
Chem Biodivers. 2020 Nov;17(11):e2000470
pubmed: 32996697
J Invest Dermatol. 2014 Jan;134(1):58-67
pubmed: 23812301
Bioorg Med Chem Lett. 2008 Jan 15;18(2):532-7
pubmed: 18068975
J Cell Sci. 2005 Jan 15;118(Pt 2):343-56
pubmed: 15632106
J Biol Chem. 2002 Nov 22;277(47):44854-63
pubmed: 12244048
Cardiovasc Res. 2016 Jun 1;110(3):298-308
pubmed: 27009176
J Biol Chem. 1989 Dec 5;264(34):20655-63
pubmed: 2511208
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2967-72
pubmed: 9501199
Proteins. 1992 Nov;14(3):327-32
pubmed: 1438172
Br J Cancer. 2010 Nov 9;103(10):1562-70
pubmed: 20959825
PLoS One. 2011;6(5):e20138
pubmed: 21647416
Diabetes. 2013 Nov;62(11):3807-16
pubmed: 23919962
Structure. 1998 Jun 15;6(6):735-46
pubmed: 9655825
J Biol Chem. 2007 Apr 27;282(17):12484-91
pubmed: 17327233
Matrix Biol. 2019 Nov;84:31-40
pubmed: 31669522
J Pept Sci. 2007 Apr;13(4):263-8
pubmed: 17394124
EMBO J. 1998 Mar 16;17(6):1588-97
pubmed: 9501080
J Biol Chem. 1983 Oct 25;258(20):12143-6
pubmed: 6415049
J Med Chem. 2018 Dec 27;61(24):11261-11279
pubmed: 30457869
Comp Biochem Physiol B Biochem Mol Biol. 2001 May;129(1):29-64
pubmed: 11337249
Histochem Cell Biol. 2015 Mar;143(3):245-58
pubmed: 25274422
Proc Natl Acad Sci U S A. 1987 Feb;84(4):995-9
pubmed: 3103130
EMBO Rep. 2001 Feb;2(2):151-6
pubmed: 11258708
J Immunol. 2007 Nov 1;179(9):6184-92
pubmed: 17947694
J Invest Dermatol. 2004 Feb;122(2):256-65
pubmed: 15009703
Clin Exp Metastasis. 2012 Jun;29(5):511-22
pubmed: 22434583
Matrix Biol. 2019 Nov;84:57-67
pubmed: 31226402
PLoS One. 2010 Nov 16;5(11):e14010
pubmed: 21103358
Cell Signal. 2012 Nov;24(11):2035-42
pubmed: 22759791
Mol Genet Metab. 2004 May;82(1):48-55
pubmed: 15110321
Glycobiology. 2016 Aug;26(8):834-49
pubmed: 27226251
Pathol Biol (Paris). 2012 Feb;60(1):28-33
pubmed: 22099332
Biochem Soc Trans. 2010 Dec;38(6):1453-7
pubmed: 21118106
Blood. 2012 Feb 2;119(5):1263-73
pubmed: 22101895
Genes Dev. 1996 Dec 15;10(24):3156-69
pubmed: 8985184
J Physiol Biochem. 2020 Aug;76(3):457-467
pubmed: 32592089
J Biol Chem. 1992 Sep 5;267(25):17949-56
pubmed: 1387645
J Clin Invest. 1993 Mar;91(3):1198-205
pubmed: 8383699
J Cell Biol. 1984 Sep;99(3):870-4
pubmed: 6547961
J Biol Chem. 2005 Jan 7;280(1):469-75
pubmed: 15501818
J Biol Chem. 1998 Mar 13;273(11):6319-26
pubmed: 9497360
J Biol Chem. 2014 Mar 28;289(13):9121-35
pubmed: 24550400
Cell Signal. 2013 Dec;25(12):2587-603
pubmed: 23993964
Diabetes. 2018 Aug;67(8):1604-1615
pubmed: 29802129
Oncogene. 2009 Mar 5;28(9):1218-29
pubmed: 19151752
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Cell Signal. 2014 Jun;26(6):1355-68
pubmed: 24583283
Am J Pathol. 2008 Oct;173(4):1042-56
pubmed: 18772331
Sci Adv. 2021 May 12;7(20):
pubmed: 33980489
Glycoconj J. 2009 Dec;26(9):1197-212
pubmed: 19430901
Clin Exp Metastasis. 2002;19(2):107-17
pubmed: 11964074
Structure. 1995 Nov 15;3(11):1249-59
pubmed: 8591035
Biomedicines. 2021 Apr 11;9(4):
pubmed: 33920466
J Vasc Surg. 2002 Feb;35(2):254-61
pubmed: 11854722
Cell Mol Life Sci. 2019 Feb;76(4):791-807
pubmed: 30498996
Wound Repair Regen. 2009 Sep-Oct;17(5):631-8
pubmed: 19769716
J Biol Chem. 2001 Feb 16;276(7):5222-7
pubmed: 11084020
Int J Mol Sci. 2014 Oct 29;15(11):19700-28
pubmed: 25356505
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2570-8
pubmed: 25341794
Curr Opin Endocr Metab Res. 2021 Feb;16:102-112
pubmed: 33748531
Biogerontology. 2010 Oct;11(5):547-63
pubmed: 20559726

Auteurs

Dignê Tembely (D)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Aubéri Henry (A)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Laetitia Vanalderwiert (L)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Kevin Toussaint (K)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Amar Bennasroune (A)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Sébastien Blaise (S)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Hervé Sartelet (H)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Stéphane Jaisson (S)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Céline Galés (C)

Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, Université de Toulouse, Toulouse, France.

Laurent Martiny (L)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Laurent Duca (L)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Béatrice Romier-Crouzet (B)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Pascal Maurice (P)

UMR CNRS 7369 Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims Champagne Ardenne (URCA), UFR Sciences Exactes et Naturelles, Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH